Robert Felsch
Comptroller/Controller/Auditor at ARDELYX, INC.
Net worth: 600 251 $ as of 29/04/2024
Network origin in Robert Felsch first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Robert Felsch via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | General Counsel Chief Executive Officer | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| NOVAVAX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member | |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Director/Board Member | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| TESARO INC | Pharmaceuticals: Major | Founder Chairman | |
Arthur D. Little, Inc.
 Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Boston University | College/University | Undergraduate Degree | |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member | |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| EPIZYME, INC. | Biotechnology | Chairman Chief Executive Officer | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Chief Operating Officer Chairman | |
Pumped Hydro Storage Sweden AB
 Pumped Hydro Storage Sweden AB Industrial MachineryProducer Manufacturing Part of Sustainable Energy Solutions Sweden Holding AB, Pumped Hydro Storage Sweden AB develops hydro pump energy storage solutions. The company is based in Noessjoe, Sweden. The Swedish company was founded in 2017 by Otto Werneskog. Pumped Hydro Storage Sweden was acquired by Sustainable Energy Solutions Sweden Holding AB on June 07, 2021 for $7.30 million. | Industrial Machinery | Director/Board Member | |
Anocca AB
 Anocca AB Miscellaneous Commercial ServicesCommercial Services Anocca AB is a Swedish biopharmaceutical company that is developing next-generation T-cell immunotherapies for the treatment of solid tumors, autoimmune diseases, and infectious diseases. The company was founded in 2014 by Jarvis Reagan and is based in Sweden. The company is building libraries of novel T-cell immunotherapies that specifically target difficult-to-treat cancers and will be moving into clinical trials in 2024. Anocca has a fully integrated research and development infrastructure, underpinned by tailor-made advanced software solutions and in-house clinical manufacturing and process development facilities. Anocca has raised over USD 100 million in funding from leading Nordic investors and secured EUR 25 million in funding from the European Investment Bank in 2022. The company's team of over 90 employees operates from its state-of-the-art R&D and manufacturing facilities. Jarvis Reagan has been the CEO since 2014. | Miscellaneous Commercial Services | Director/Board Member | |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor | |
| ALZECURE PHARMA AB | Biotechnology | Director/Board Member | |
| DePauw University | College/University | Undergraduate Degree | |
| DICE THER | Biotechnology | Human Resources Officer | |
| STALLERGENES GREER | Pharmaceuticals: Major | Public Communications Contact | |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Biotechnology | Director/Board Member | |
Balticgruppen Bio AB
 Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Balticgruppen Bio AB is a Swedish biopharmaceutical company that develops activated protein kinase. The company was founded by Olof Karlsson, Thomas Edlund, and Helena Edlund. Thomas Edlund has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
| TEMPEST THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| Boston University School of Medicine | College/University | Doctorate Degree | |
| Cuba Emprende Foundation | Director/Board Member | ||
| Stanford Law School | College/University | Graduate Degree | |
| San Francisco State University | College/University | Undergraduate Degree | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
| Albany Medical College | College/University | Graduate Degree |
Statistics
International
| United States | 36 |
| Sweden | 7 |
| United Kingdom | 5 |
| Israel | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 8 |
| Commercial Services | 7 |
| Finance | 4 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 103 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 37 |
| Chairman | 23 |
| Undergraduate Degree | 15 |
Most connected contacts
| Insiders | |
|---|---|
| David Mott | 45 |
| Jan Lundberg | 21 |
| Mike Raab Raab | 20 |
| Gordon Ringold | 20 |
| Muna Bhanji | 16 |
| William Bertrand | 16 |
| Richard Rodgers | 13 |
| Justin Renz | 12 |
| Susan Rodriguez | 11 |
| Robert Bazemore | 11 |
| Robert Blanks | 8 |
| Geoffrey A. Block | 8 |
| Onaiza Cadoret-Manier | 8 |
| Elizabeth Grammer | 7 |
| David Rosenbaum | 7 |
- Stock Market
- Insiders
- Robert Felsch
- Company connections
